The size of the treatment effect: Do patients and proxies agree?

BMC Neurology

Volumn 9, Issue , 2009, Pages

  van der Linden, Femke A H ^a   Kragt, Jolijn J ^a   Hobart, Jeremy C ^b,c   Klein, Martin ^a   Thompson, Alan J ^b   van der Ploeg, Henk M ^a   Polman, Chris H ^a   Uitdehaag, Bernard M J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSTODY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICAL CAPACITY; PSYCHOLOGICAL WELL BEING; RATING SCALE; SCORING SYSTEM; SELF EVALUATION; TREATMENT RESPONSE; DAILY LIFE ACTIVITY; EPIDEMIOLOGY; HEALTH STATUS; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATIENT; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; ROC CURVE; STATISTICS; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATIENTS; PROXY; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX; STEROIDS; TREATMENT OUTCOME;

EID: 64849100318     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-9-12     Document Type: Article

References (27)

1. Lublin FD Reingold SC Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 1996, 46:907-911. 8780061
2. Hoogervorst EL Eikelenboom MJ Uitdehaag BM Polman CH One year changes in disability in multiple sclerosis: Neurological examination compared with patient self report J Neurol Neurosurg Psychiatry 2003, 74:439:442. 1738360 12640058 10.1136/jnnp.74.4.439
3. Rao SM Leo GJ Bernardin L Unverzagt F Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction Neurology 1991, 41:685-691. 2027484
4. Amato MP Zipoli V Portaccio E Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies J Neurol Sci 2006, 245:41-46. 10.1016/j.jns.2005.08.019 16643953
5. Sadovnick AD Remick RA Allen J Swartz E Yee IM Eisen K et al Depression and multiple sclerosis Neurology 1996, 46:628-632. 8618657
6. Korostil M Feinstein A Anxiety disorders and their clinical correlates in multiple sclerosis patients Mult Scler 2007, 13:67-72. 10.1177/ 1352458506071161 17294613
7. Sprangers MA Aaronson NK The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review J Clin Epidemiol 1992, 45:743-760. 10.1016/ 0895-4356(92)90052-O 1619454
8. Linden van der FA Kragt JJ Hobart JC Klein M Thompson AJ Ploeg van der HM et al Proxy measurements in multiple sclerosis: Agreement between patients and their partners on the impact of multiple sclerosis in daily life J Neurol Neurosurg Psychiatry 2006, 77:1157-1162. 10.1136/ jnnp.2006.090795 16820417
9. Hobart JC Riazi A Lamping DL Fitzpatrick R Thompson AJ How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales J Neurol Neurosurg Psychiatry 2005, 76:1539-1543. 1739386 16227547 10.1136/jnnp.2005.064584
10. Hobart J Lamping D Fitzpatrick R Riazi A Thompson A The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure Brain 2001, 124:962-973. 10.1093/brain/124.5.962 11335698
11. Pickard AS Knight SJ Proxy evaluation of health-related quality of life: a conceptual framework for understanding multiple proxy perspectives Med Care 2005, 43:493-499. 1188232 15838415 10.1097/ 01.mlr.0000160419.27642.a8
12. Guyatt GH Norman GR Juniper EF Griffith LE A critical look at transition ratings J Clin Epidemiol 2002, 55:900-908. 10.1016/S0895-4356(02)00435-3 12393078
13. Cohen J Statistical power analysis for the behavioral sciences Hillsdale, New Jersey: Lawrence Erlbaum Associates 1988, 19-74.
14. Bland JM Altman DG Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1986, 1:307-310. 2868172
15. Bland JM Altman DG A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement Comput Biol Med 1990, 20:337-340. 10.1016/ 0010-4825(90)90013-F 2257734
16. Lee J Koh D Ong CN Statistical evaluation of agreement between two methods for measuring a quantitative variable Comput Biol Med 1989, 19:61-70. 10.1016/0010-4825(89)90036-X 2917462
17. McGraw KO Wong SP Forming inferences about some intraclass correlation coefficients Psychological Methods 1996, 1:30-46. 10.1037/ 1082-989X.1.1.30
18. Nunnally JC Bernstein IH Psychometric theory New York: McGraw-Hill 3, 1994.
19. Guyatt G Walter S Norman G Measuring change over time: Assessing the usefulness of evaluative instruments J Chronic Dis 1987, 40:171-178. 10.1016/0021-9681(87)90069-5 3818871
20. de Vet HC Bouter LM Bezemer PD Beurskens AJ Reproducibility and responsiveness of evaluative outcome measures. Theoretical considerations illustrated by an empirical example Int J Technol Assess Health Care 2001, 17:479-487. 10.1017/S0266462301106148 11758292
21. de Vet HC Ostelo RW Terwee CB van der RN Knol DL Beckerman H et al Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach Qual Life Res 2007, 16:131-142. 10.1007/s11136-006-9109-9 17033901
22. Husted JA Cook RJ Farewell VT Gladman DD Methods for assessing responsiveness: A critical review and recommendations J Clin Epidemiol 2000, 53:459-468. 10.1016/S0895-4356(99)00206-1 10812317
23. Hobart JC Riazi A Lamping DL Fitzpatrick R Thompson AJ Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome Health Technol Assess 2004, 8. 14982653
24. Linden van der FA Kragt JJ van BM Klein M Thompson AJ Ploeg van der HM et al Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years BMC Neurol 2008, 8:2. 2270863 18307788 10.1186/1471-2377-8-2
25. Costelloe L O'Rourke K Kearney H McGuigan C Gribbin L Duggan M et al The patient knows best: Significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical) J Neurol Neurosurg Psychiatry 2007, 78:841-844. 10.1136/jnnp.2006.105759 17332049
26. Norman GR Stratford P Regehr G Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach J Clin Epidemiol 1997, 50:869-879. 10.1016/ S0895-4356(97)00097-8 9291871
27. Ross M Relation of implicit theories to the construction of personal histories Psychol Rev 1989, 96:341-357. 10.1037/0033-295X.96.2.341